c.1293_1312del20(p.Gln433Aspfs*66)
Case29
HPOsFreeText: See Group Phenotypes
CasePreviousTesting: Sanger sequencing
CaseMethod1: Sanger sequencing and PCR Amplification
CaseMethod2: Whole Exome Sequencing (WES)
CaseGenotypingMethod: Patients were previously confirmed with Pompe disease by Sanger sequencing to capture the pathogenic variants. The process was repeated as part of the study taking care to amplify the coding regions and exon/intron boundaries to compare with the WES results afterwards.
Variant1: NM_000152.4:c.1293_1312del (p.Gln433Aspfs*66)
CAID: CA658795249 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.1293_1312del
gnomAD: Not in gnomAD
Variant2: NM_000152.4:c.1716C>G (p.His572Gln)
CAID: CA401369055 https://reg.clinicalgenome.org/redmine/projects/registry/genboree_registry/allele?hgvs=NM_000152.4%3Ac.1716C%3EG
gnomAD: Not in gnomAD
CaseAddInfo: Infantile Onset Pompe Disease